Emerging Biotech Partnerships

Atomwise helps emerging biotechnology companies accelerate their innovations with AI-based drug discovery.

Fueling Innovation with AI-based Drug Discovery

Emerging biotechnology companies don't always have access to the most cutting edge tools for AI and machine learning. Partnership with Atomwise gives them this access so they can transform their discoveries into drug programs.

Creating New Business Opportunities Together

The synergy of the biology exploration by our partners and chemical exploration with our AtomNet® technology creates discoveries that neither partner could have achieved alone. Together we form joint ventures to advance therapies for disease areas with unmet needs.

Working with Atomwise can create commercial opportunities for our academic partners:

SEE OUR PORTFOLIO OF JOINT VENTURE COMPANIES SEE OUR JOINT VENTURE CO-DEVELOPMENT PIPELINE

Emerging Biotech Partner News

Atomwise As Your Business Partner

Our JV support offers added value by providing resources, expertise, and professional services throughout the entrepreneurship journey.

Scientific Expertise
Brand Awareness
Legal
Partnering
Operations
Marketing Opportunities

Drug Development Support

Our ecosystem includes partners for chemical synthesis, assay development, and pre-clinical studies, helping our partners advance through drug discovery process.


Investor Network

Atomwise can create connections that drive value and investment through marketing resources, incubators and accelerator programs, seed and venture capital.

Explore partnerships to find new medicines with AI.

Contact us to learn more about our partnering opportunities.

Contact Partnering